Quarry LP’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.6K Sell
1,460
-8,540
-85% -$318K 0.01% 589
2026
Q1
$402K Buy
+10,000
New +$431K 0.07% 191
2025
Q3
Sell
-5,500
Closed -$130K 2524
2025
Q2
$130K Buy
5,500
+3,000
+120% +$67.5K 0.03% 460
2025
Q1
$60K Buy
2,500
+500
+25% +$16.1K 0.01% 718
2024
Q4
$84.6K Sell
2,000
-300
-13% -$13.3K 0.01% 504
2024
Q3
$102K Sell
2,300
-4,200
-65% -$159K 0.03% 426
2024
Q2
$235K Buy
+6,500
New +$258K 0.07% 141

Other funds holding VERA

Quarry LP's VERA Position: Q2 2026 in Review

Quarry LP reduced its Vera Therapeutics (VERA) stake by 85% in Q2 2026, selling an estimated $318K and leaving 1,460 shares worth $62.6K. The position accounts for 0.01% of the portfolio, ranked #589.

Quarry LP first reported a position in VERA in Q2 2024 and has held it in 7 quarters since. The position peaked at $402K in Q1 2026. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Quarry LP held 1,460 shares of Vera Therapeutics worth $62.6K as of Q2 2026.
  • Quarry LP sold 8,540 Vera Therapeutics shares in Q2 2026, an estimated $318K.
  • Vera Therapeutics made up 0.01% of Quarry LP's portfolio in Q2 2026, its #589 holding.
  • Quarry LP first reported a position in Vera Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Quarry LP's Vera Therapeutics position peaked at $402K in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.